Infection Prevention Strategies for Dialysis Patients with a Central Venous Catheter (CVC) скачать в хорошем качестве

Infection Prevention Strategies for Dialysis Patients with a Central Venous Catheter (CVC)

A webinar in support of AAKP’s National “Every Patient Safe” Campaign! AAKP is working hard to educate and activate kidney patients to demand access to new innovations that can help make their dialysis treatments safer. Individuals on hemodialysis, who are dependent upon a central venous catheter (CVC) as their vascular access for life-saving treatments are at an increased risk of exposure to Cather-Related Bloodstream Infections (CRBSIs). The likelihood of developing a CRBSI increases with improper care, poor hygiene practices, and inadequate monitoring. These infections are life-threatening and extremely costly. Additionally, these types of infections can occur even when rigorous infection prevention methods are used – but are limited to the outside parts of the catheter or to the immediate ‘hub.” New innovations are available to help address infections that happen on the inside of the catheter. Watch this HealthLine webinar, part of AAKP’s “Every Patient Safe” series, to learn more about how you and your dialysis facility can protect your CVC and help avoid infections – and how you can educate other patients through AAKP’s national “Every Patient Safe” campaign! Moderator: Jerome Bailey, AAKP Director of Patient Engagement and Advocacy Speakers: Paul Conway, AAKP Vice President, AAKP Chair of Policy & Global Affairs, Kidney Transplant Recipient Liz Hurlburt, Executive Vice President & Chief Clinical Strategy & Operations Officer, CorMedix, Inc. Dawn Edwards, AAKP Ambassador, Dialysis Patient Michael Gilchrist, AAKP Ambassador, Care Partner As the oldest and largest, independent kidney patient organization in the U.S. – AAKP is dedicated to improving the lives and long-term outcomes of kidney patients through education, advocacy, patient engagement, and the fostering of patient communities. AAKP fights for early disease detection and the appropriate diagnosis of rare/genetic conditions; increased kidney transplantation and pre-emptive transplantation; full patient choice of either in-center or home dialysis; protection of the patient/physician relationship; promotion of research and innovation including artificial implantable and wearable kidneys; and the elimination of barriers for patient access to available treatment options. Learn more at www.aakp.org.